首页 > 最新文献

Journal of geriatric oncology最新文献

英文 中文
Evaluation protocol for older adults with hematologic malignancies in a Latin American Cancer Center 拉丁美洲癌症中心老年人血液恶性肿瘤的评估方案
IF 2.7 3区 医学 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2026-03-01 Epub Date: 2026-03-13 DOI: 10.1016/j.jgo.2026.102878
S. Borquez , R. Quilodrán , G. Godoy , C. Cabrera , G. Gajardo
{"title":"Evaluation protocol for older adults with hematologic malignancies in a Latin American Cancer Center","authors":"S. Borquez , R. Quilodrán , G. Godoy , C. Cabrera , G. Gajardo","doi":"10.1016/j.jgo.2026.102878","DOIUrl":"10.1016/j.jgo.2026.102878","url":null,"abstract":"","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102878"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inclusion of older adult-specific policies in national cancer control plans (NCCPs) and non-communicable disease plans (NCDPs) 将针对老年人的政策纳入国家癌症控制计划和非传染性疾病计划
IF 2.7 3区 医学 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2026-03-01 Epub Date: 2026-03-13 DOI: 10.1016/j.jgo.2026.102871
D. Dulak , D. Trapani , Y. Romero , E. Soto Pérez de Celis
{"title":"Inclusion of older adult-specific policies in national cancer control plans (NCCPs) and non-communicable disease plans (NCDPs)","authors":"D. Dulak , D. Trapani , Y. Romero , E. Soto Pérez de Celis","doi":"10.1016/j.jgo.2026.102871","DOIUrl":"10.1016/j.jgo.2026.102871","url":null,"abstract":"","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102871"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Senior adult oncology program at Moffitt Cancer Center- An innovative multidisciplinary care approach 莫菲特癌症中心的高级成人肿瘤项目-一种创新的多学科护理方法
IF 2.7 3区 医学 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2026-03-01 Epub Date: 2026-03-13 DOI: 10.1016/j.jgo.2026.102903
M. Extermann
The Senior Adult Oncology Program at Moffitt is a pioneering Geriatric Oncology Care Model that focuses on a multi-disciplinary team approach to optimizing care of older adults. The team is comprised of dedicated medical oncologists, nurse practioners, medical assistants, nursing team, dietician, social work, and pharmacy who assess and treat the patient with a comprehensive approach, not only focusing on the cancer, but also addressing any physical, nutritional, and psychosocial issues that could impact their care.
Our approach starts with a nurse initiating a phone call to the patient within 72 hours of appointment scheduling. During this call, the SAOP3 Questionnaire is performed to identify any needs prior to the visit. If there is a negative screen, the patient proceeds with usual care and management with the oncologist. If there is a positive screen along a geriatric domain, this initiates further workup, and appointments are scheduled with the social work, dietician, and pharmacist for the day of the appointment. This allows patients to have a planned comprehensive evaluation on the day of the visit, without the burden of multiple followup appointments.
On the day of the visit, the medical assistant guides the patient to perform the Timed Up and Go test after completing the vitals, and the clinic nurse completes a mini-COG with the patient during the nursing evaluation. These evaluations are given to the oncologist prior to the oncologist’s visit with the patient. Once they have been completely evaluated, a treatment plan is made, taking into account all the other assessments that have been performed by the team. This plan is then discussed at a weekly tumor board, which is attended by all members of the program to get final input on the plan of care.
Throughout the patient’s care at Moffitt, the SAOP3, TUG, and mini-COG may be repeated at varying intervals, such as changes in treatment, after hospitalizations, or after falls. This is an ongoing area of research within our team to identify optimal time points for repetition of these assessments.
Moffitt的高级成人肿瘤项目是一个开创性的老年肿瘤护理模式,专注于多学科团队方法来优化老年人的护理。该团队由专业的肿瘤学家、执业护士、医疗助理、护理团队、营养师、社会工作人员和药房组成,他们以全面的方法评估和治疗患者,不仅关注癌症,还解决任何可能影响其护理的身体、营养和社会心理问题。我们的方法是从护士在预约安排的72小时内给病人打电话开始的。在拜访期间,进行SAOP3问卷调查,以确定访问前的任何需求。如果筛查结果为阴性,则患者继续接受肿瘤学家的常规护理和管理。如果筛查结果呈阳性,则开始进一步检查,并在预约当天与社会工作人员、营养师和药剂师预约。这使得患者可以在就诊当天进行计划全面的评估,而无需多次随访预约的负担。访视当日,医助在完成生命体征检查后指导患者进行Timed Up and Go测试,门诊护士在护理评估过程中与患者一起完成mini-COG。这些评估在肿瘤科医生拜访病人之前交给肿瘤科医生。一旦他们被完全评估,就会制定一个治疗计划,考虑到团队已经完成的所有其他评估。该计划随后在每周一次的肿瘤委员会上进行讨论,该委员会由项目的所有成员参加,以获得对护理计划的最终投入。在莫菲特医院的整个治疗过程中,SAOP3、TUG和mini-COG可以在不同的时间间隔重复进行,例如治疗的改变、住院后或跌倒后。这是我们团队正在进行的研究领域,以确定重复这些评估的最佳时间点。
{"title":"Senior adult oncology program at Moffitt Cancer Center- An innovative multidisciplinary care approach","authors":"M. Extermann","doi":"10.1016/j.jgo.2026.102903","DOIUrl":"10.1016/j.jgo.2026.102903","url":null,"abstract":"<div><div>The Senior Adult Oncology Program at Moffitt is a pioneering Geriatric Oncology Care Model that focuses on a multi-disciplinary team approach to optimizing care of older adults. The team is comprised of dedicated medical oncologists, nurse practioners, medical assistants, nursing team, dietician, social work, and pharmacy who assess and treat the patient with a comprehensive approach, not only focusing on the cancer, but also addressing any physical, nutritional, and psychosocial issues that could impact their care.</div><div>Our approach starts with a nurse initiating a phone call to the patient within 72 hours of appointment scheduling. During this call, the SAOP3 Questionnaire is performed to identify any needs prior to the visit. If there is a negative screen, the patient proceeds with usual care and management with the oncologist. If there is a positive screen along a geriatric domain, this initiates further workup, and appointments are scheduled with the social work, dietician, and pharmacist for the day of the appointment. This allows patients to have a planned comprehensive evaluation on the day of the visit, without the burden of multiple followup appointments.</div><div>On the day of the visit, the medical assistant guides the patient to perform the Timed Up and Go test after completing the vitals, and the clinic nurse completes a mini-COG with the patient during the nursing evaluation. These evaluations are given to the oncologist prior to the oncologist’s visit with the patient. Once they have been completely evaluated, a treatment plan is made, taking into account all the other assessments that have been performed by the team. This plan is then discussed at a weekly tumor board, which is attended by all members of the program to get final input on the plan of care.</div><div>Throughout the patient’s care at Moffitt, the SAOP3, TUG, and mini-COG may be repeated at varying intervals, such as changes in treatment, after hospitalizations, or after falls. This is an ongoing area of research within our team to identify optimal time points for repetition of these assessments.</div></div>","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102903"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147449068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiotoxicity in older patients with HER2-positive early breast cancer undergoing neoadjuvant dual HER2 blockade and chemotherapy: A real-world cohort study 接受新辅助双重HER2阻断和化疗的老年HER2阳性早期乳腺癌患者的心脏毒性:一项现实世界队列研究
IF 2.7 3区 医学 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2026-03-01 Epub Date: 2026-03-13 DOI: 10.1016/j.jgo.2026.102868
I. Furtado, R. Ferreira, R. Escaleira, F. Verdasca, M. Seladas, A. Montenegro, D. Simão, L. Fernandes, S. Oliveira
{"title":"Cardiotoxicity in older patients with HER2-positive early breast cancer undergoing neoadjuvant dual HER2 blockade and chemotherapy: A real-world cohort study","authors":"I. Furtado,&nbsp;R. Ferreira,&nbsp;R. Escaleira,&nbsp;F. Verdasca,&nbsp;M. Seladas,&nbsp;A. Montenegro,&nbsp;D. Simão,&nbsp;L. Fernandes,&nbsp;S. Oliveira","doi":"10.1016/j.jgo.2026.102868","DOIUrl":"10.1016/j.jgo.2026.102868","url":null,"abstract":"","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102868"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147449071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BDNF genotype and cognition in older adults with breast cancer and healthy controls in the Thinking and Living with Cancer Study 老年乳腺癌患者及健康对照者的BDNF基因型与认知
IF 2.7 3区 医学 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2026-03-01 Epub Date: 2025-12-10 DOI: 10.1016/j.jgo.2025.102834
Zev M. Nakamura , Brent J. Small , Xingtao Zhou , Jaeil Ahn , Tim A. Ahles , Ashley L. Artese , Harvey Jay Cohen , Martine Extermann , Deena Graham , Claudine Isaacs , Heather S.L. Jim , Brenna C. McDonald , Kelly Nudelman , Sunita K. Patel , Kelly E. Rentscher , James C. Root , Andrew J. Saykin , Kathleen Van Dyk , Claire E. Wegel , Jeanne S. Mandelblatt , Judith E. Carroll
{"title":"BDNF genotype and cognition in older adults with breast cancer and healthy controls in the Thinking and Living with Cancer Study","authors":"Zev M. Nakamura ,&nbsp;Brent J. Small ,&nbsp;Xingtao Zhou ,&nbsp;Jaeil Ahn ,&nbsp;Tim A. Ahles ,&nbsp;Ashley L. Artese ,&nbsp;Harvey Jay Cohen ,&nbsp;Martine Extermann ,&nbsp;Deena Graham ,&nbsp;Claudine Isaacs ,&nbsp;Heather S.L. Jim ,&nbsp;Brenna C. McDonald ,&nbsp;Kelly Nudelman ,&nbsp;Sunita K. Patel ,&nbsp;Kelly E. Rentscher ,&nbsp;James C. Root ,&nbsp;Andrew J. Saykin ,&nbsp;Kathleen Van Dyk ,&nbsp;Claire E. Wegel ,&nbsp;Jeanne S. Mandelblatt ,&nbsp;Judith E. Carroll","doi":"10.1016/j.jgo.2025.102834","DOIUrl":"10.1016/j.jgo.2025.102834","url":null,"abstract":"","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102834"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145735297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring decisional control preferences in older patients with cancer and their caregivers 探讨老年癌症患者及其照顾者的决策控制偏好
IF 2.7 3区 医学 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2026-03-01 Epub Date: 2025-12-12 DOI: 10.1016/j.jgo.2025.102832
Sofiia Hryniv , Elizabeth Gilbride , William Consagra , Supriya Mohile , Sule Yilmaz , Kaitlin Kyi , Sindhuja Kadambi , Marielle Jensen-Battaglia , Nikesha Gilmore , Mary Whitehead , Jamil Khatri , Fadi S. Braiteh , Alison Conlin , Kah Poh Loh , Allison Magnuson

Introduction

Exploring informational and decisional control preferences as well as examining concordance and patient-caregiver-physician factors associated with preferences in older adults with cancer and their caregivers may help to better understand the role of caregivers in supporting decision-making.

Materials and methods

We utilized data from a national geriatric assessment (GA) cluster-randomized trial (NCT 02054741; PI: Mohile) that recruited patients aged ≥70 with incurable cancer, their caregivers, and oncologists. Dyadic decision-making control preferences were measured by the Control Preferences Scale (CPS). Patients and caregivers were asked to describe patient's role in treatment decision-making (patient-role CPS); patients and caregivers were also asked to describe the caregiver's role in treatment decision-making (caregiver-role CPS). Matching patient-caregiver responses were considered concordant. Patients and caregivers were also asked about their information preferences regarding the amount of detail about the patients' illness using a scale from 1 (fewest detail) to 5 (the most detail). We used descriptive statistics to summarize CPS, informational preferences, and concordance in responses. We utilized logistic regression to assess dyads' sociodemographic information, patients' GA domain impairments, and physicians' practice characteristics associated with patient-caregiver CPS concordance.

Results

A total of 332 dyads participated; mean age (SD) of patients and caregivers was 76.6 (5.3) and 66.6 (12.2), respectively. Preferences for treatment decision-making varied, with some preferring shared decision-making and others preferring the doctor to make decisions. Concordance between patients and caregivers was observed in 46 % for patient-role CPS and 54 % for caregiver-role CPS. Baseline factors were not associated with dyad concordance. The majority of patients and caregivers preferred the most detailed information about the patient's illness.

Discussion

Clinicians should assess patients' and caregivers' informational and decisional control preferences for optimal support in decision-making.
探索信息和决策控制偏好,以及检查与老年癌症患者及其护理人员偏好相关的一致性和患者-护理人员-医生因素,可能有助于更好地理解护理人员在支持决策中的作用。材料和方法我们使用了一项国家老年评估(GA)集群随机试验(NCT 02054741; PI: mohiile)的数据,该试验招募了年龄≥70岁的无法治愈的癌症患者、他们的护理人员和肿瘤学家。采用控制偏好量表(CPS)测量二元决策控制偏好。患者和护理人员被要求描述患者在治疗决策中的角色(患者-角色CPS);患者和照顾者也被要求描述照顾者在治疗决策中的角色(照顾者-角色CPS)。匹配的患者-护理者反应被认为是和谐的。患者和护理人员也被问及他们对患者疾病细节数量的信息偏好,使用从1(最少细节)到5(最细节)的量表。我们使用描述性统计来总结CPS、信息偏好和响应的一致性。我们使用逻辑回归来评估与患者-护理人员CPS一致性相关的二人组的社会人口统计信息、患者的GA域损伤和医生的实践特征。结果共332人参加;患者和护理人员的平均年龄(SD)分别为76.6岁(5.3岁)和66.6岁(12.2岁)。人们对治疗决策的偏好各不相同,一些人更喜欢共同决策,而另一些人更喜欢医生做决定。患者和护理人员之间的一致性在46%的患者角色CPS和54%的护理人员角色CPS中被观察到。基线因素与双染色体一致性无关。大多数患者和护理人员更喜欢关于患者疾病的最详细的信息。临床医生应该评估患者和护理人员的信息和决策控制偏好,以获得最佳的决策支持。
{"title":"Exploring decisional control preferences in older patients with cancer and their caregivers","authors":"Sofiia Hryniv ,&nbsp;Elizabeth Gilbride ,&nbsp;William Consagra ,&nbsp;Supriya Mohile ,&nbsp;Sule Yilmaz ,&nbsp;Kaitlin Kyi ,&nbsp;Sindhuja Kadambi ,&nbsp;Marielle Jensen-Battaglia ,&nbsp;Nikesha Gilmore ,&nbsp;Mary Whitehead ,&nbsp;Jamil Khatri ,&nbsp;Fadi S. Braiteh ,&nbsp;Alison Conlin ,&nbsp;Kah Poh Loh ,&nbsp;Allison Magnuson","doi":"10.1016/j.jgo.2025.102832","DOIUrl":"10.1016/j.jgo.2025.102832","url":null,"abstract":"<div><h3>Introduction</h3><div>Exploring informational and decisional control preferences as well as examining concordance and patient-caregiver-physician factors associated with preferences in older adults with cancer and their caregivers may help to better understand the role of caregivers in supporting decision-making.</div></div><div><h3>Materials and methods</h3><div>We utilized data from a national geriatric assessment (GA) cluster-randomized trial (NCT 02054741; PI: Mohile) that recruited patients aged ≥70 with incurable cancer, their caregivers, and oncologists. Dyadic decision-making control preferences were measured by the Control Preferences Scale (CPS). Patients and caregivers were asked to describe patient's role in treatment decision-making (patient-role CPS); patients and caregivers were also asked to describe the caregiver's role in treatment decision-making (caregiver-role CPS). Matching patient-caregiver responses were considered concordant. Patients and caregivers were also asked about their information preferences regarding the amount of detail about the patients' illness using a scale from 1 (fewest detail) to 5 (the most detail). We used descriptive statistics to summarize CPS, informational preferences, and concordance in responses. We utilized logistic regression to assess dyads' sociodemographic information, patients' GA domain impairments, and physicians' practice characteristics associated with patient-caregiver CPS concordance.</div></div><div><h3>Results</h3><div>A total of 332 dyads participated; mean age (SD) of patients and caregivers was 76.6 (5.3) and 66.6 (12.2), respectively. Preferences for treatment decision-making varied, with some preferring shared decision-making and others preferring the doctor to make decisions. Concordance between patients and caregivers was observed in 46 % for patient-role CPS and 54 % for caregiver-role CPS. Baseline factors were not associated with dyad concordance. The majority of patients and caregivers preferred the most detailed information about the patient's illness.</div></div><div><h3>Discussion</h3><div>Clinicians should assess patients' and caregivers' informational and decisional control preferences for optimal support in decision-making.</div></div>","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102832"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145735296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening for frailty and malnutrition in a multidisciplinary head and neck cancer program 筛查虚弱和营养不良的多学科头颈癌项目。
IF 2.7 3区 医学 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-16 DOI: 10.1016/j.jgo.2026.102892
Eden R. Brauer , Stephanie Lazaro , Denice R. Economou , David Rapkin , Deborah J. Wong , Maie A. St. John

Introduction

Frailty and malnutrition are strong predictors of adverse outcomes in patients with head and neck cancer, yet remain underassessed in routine clinical care. This project aimed to develop, implement, and evaluate a standardized screening process for frailty and malnutrition in a multidisciplinary head and neck cancer program to identify high-risk patients and inform treatment planning.

Materials and methods

Through a quality improvement initiative, a multidisciplinary team integrated the Risk Analysis Index for Cancer (RAI-C) for frailty and Malnutrition Screening Tool (MST) into routine intake for new referrals of patients with head and neck cancer. Implementation was evaluated across three domains: feasibility, measured through completion rates, acceptability, assessed using clinician feedback via a survey, and impact on patient outcomes, using survival analysis.

Results

Among 585 eligible patients, 488 (83.4%) were successfully screened. The cohort (mean age 63.1 years, 64% male) demonstrated high frailty prevalence with 57.2% categorized as frail (RAI-C score ≥ 37) and 14.3% at risk for malnutrition (MST score ≥ 2). In multivariable analysis adjusted for tumor site, treatment intensity, and comorbidities, frail patients had a more than 3-fold increased mortality risk compared to non-frail patients (adjusted HR 3.07, 95% CI 1.50–6.30, p = 0.002). Similarly, malnourished patients showed a 2.8-fold increased mortality risk compared to non-malnourished patients (adjusted HR 2.77, 95% CI 1.52–5.03, p < 0.001). Clinician feedback (n = 14) emphasized the value of screening in promoting “whole person” treatment planning, with suggestions for developing standardized pathways for interventions based on screening results.

Discussion

Implementing frailty and malnutrition screening in multidisciplinary head and neck cancer care is feasible, acceptable to clinicians, and identifies patients at significantly higher mortality risk. The strong association between screening results and survival validates these tools' clinical utility and supports their integration into routine practice. Future directions include developing a structured prehabilitation program targeted to modifiable risk factors identified through screening to potentially improve outcomes in this vulnerable population.
简介:虚弱和营养不良是头颈癌患者不良结局的有力预测因素,但在常规临床护理中仍被低估。该项目旨在制定、实施和评估一个多学科头颈癌项目中虚弱和营养不良的标准化筛查过程,以识别高风险患者并为治疗计划提供信息。材料和方法:通过一项质量改进计划,一个多学科团队将癌症风险分析指数(rac)虚弱和营养不良筛查工具(MST)整合到头颈癌患者的常规摄入中。通过三个方面对实施进行评估:可行性,通过完成率来衡量,可接受性,通过临床医生的调查反馈来评估,以及对患者结果的影响,使用生存分析。结果:在585例符合条件的患者中,成功筛查488例(83.4%)。该队列(平均年龄63.1岁,64%为男性)显示出高虚弱患病率,其中57.2%被归类为虚弱(RAI-C评分≥37),14.3%有营养不良风险(MST评分≥2)。在对肿瘤部位、治疗强度和合并症进行校正的多变量分析中,体弱患者的死亡风险比非体弱患者增加3倍以上(调整后HR 3.07, 95% CI 1.50-6.30, p = 0.002)。同样,与非营养不良患者相比,营养不良患者的死亡风险增加了2.8倍(调整后的HR 2.77, 95% CI 1.52-5.03, p)。讨论:在多学科头颈癌护理中实施虚弱和营养不良筛查是可行的,临床医生可以接受,并且可以识别出死亡风险显着较高的患者。筛查结果与生存率之间的密切联系验证了这些工具的临床效用,并支持它们融入常规实践。未来的方向包括制定一个结构化的康复计划,针对通过筛查确定的可改变的风险因素,以潜在地改善这一弱势群体的预后。
{"title":"Screening for frailty and malnutrition in a multidisciplinary head and neck cancer program","authors":"Eden R. Brauer ,&nbsp;Stephanie Lazaro ,&nbsp;Denice R. Economou ,&nbsp;David Rapkin ,&nbsp;Deborah J. Wong ,&nbsp;Maie A. St. John","doi":"10.1016/j.jgo.2026.102892","DOIUrl":"10.1016/j.jgo.2026.102892","url":null,"abstract":"<div><h3>Introduction</h3><div>Frailty and malnutrition are strong predictors of adverse outcomes in patients with head and neck cancer, yet remain underassessed in routine clinical care. This project aimed to develop, implement, and evaluate a standardized screening process for frailty and malnutrition in a multidisciplinary head and neck cancer program to identify high-risk patients and inform treatment planning.</div></div><div><h3>Materials and methods</h3><div>Through a quality improvement initiative, a multidisciplinary team integrated the Risk Analysis Index for Cancer (RAI-C) for frailty and Malnutrition Screening Tool (MST) into routine intake for new referrals of patients with head and neck cancer. Implementation was evaluated across three domains: feasibility, measured through completion rates, acceptability, assessed using clinician feedback via a survey, and impact on patient outcomes, using survival analysis.</div></div><div><h3>Results</h3><div>Among 585 eligible patients, 488 (83.4%) were successfully screened. The cohort (mean age 63.1 years, 64% male) demonstrated high frailty prevalence with 57.2% categorized as frail (RAI-C score ≥ 37) and 14.3% at risk for malnutrition (MST score ≥ 2). In multivariable analysis adjusted for tumor site, treatment intensity, and comorbidities, frail patients had a more than 3-fold increased mortality risk compared to non-frail patients (adjusted HR 3.07, 95% CI 1.50–6.30, <em>p</em> = 0.002). Similarly, malnourished patients showed a 2.8-fold increased mortality risk compared to non-malnourished patients (adjusted HR 2.77, 95% CI 1.52–5.03, <em>p</em> &lt; 0.001). Clinician feedback (<em>n</em> = 14) emphasized the value of screening in promoting “whole person” treatment planning, with suggestions for developing standardized pathways for interventions based on screening results.</div></div><div><h3>Discussion</h3><div>Implementing frailty and malnutrition screening in multidisciplinary head and neck cancer care is feasible, acceptable to clinicians, and identifies patients at significantly higher mortality risk. The strong association between screening results and survival validates these tools' clinical utility and supports their integration into routine practice. Future directions include developing a structured prehabilitation program targeted to modifiable risk factors identified through screening to potentially improve outcomes in this vulnerable population.</div></div>","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102892"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146213342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tolerability of docetaxel in octogenarians with metastatic prostate cancer in the triplet therapy era: A single-center retrospective cohort study 在三联疗法时代,多西他赛对80多岁转移性前列腺癌的耐受性:一项单中心回顾性队列研究
IF 2.7 3区 医学 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2026-03-01 Epub Date: 2025-12-25 DOI: 10.1016/j.jgo.2025.102844
Kimitsugu Usui, Atsuto Suzuki, Hayato Kubo, Takahiro Matsumoto, Tomohiko Aigase, Takeshi Kishida, Noboru Nakaigawa
{"title":"Tolerability of docetaxel in octogenarians with metastatic prostate cancer in the triplet therapy era: A single-center retrospective cohort study","authors":"Kimitsugu Usui,&nbsp;Atsuto Suzuki,&nbsp;Hayato Kubo,&nbsp;Takahiro Matsumoto,&nbsp;Tomohiko Aigase,&nbsp;Takeshi Kishida,&nbsp;Noboru Nakaigawa","doi":"10.1016/j.jgo.2025.102844","DOIUrl":"10.1016/j.jgo.2025.102844","url":null,"abstract":"","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102844"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145837494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of hospital volume on mortality in adult women over 65 with triple-negative breast cancer 医院容量对65岁以上三阴性乳腺癌成年妇女死亡率的影响
IF 2.7 3区 医学 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2026-03-01 Epub Date: 2025-12-20 DOI: 10.1016/j.jgo.2025.102845
Barnabas T. Obeng-Gyasi , Demond L. Handley , Mohamed I. Elsaid , Eric Schupp , Daniel G. Stover , J.C. Chen , Jesus D. Anampa , Xiaoyi Teng , Samilia Obeng-Gyasi

Introduction

Older adults (≥65 years) with triple-negative breast cancer (TNBC) have higher mortality rates than younger patients, due in part to greater comorbidity and lower rates of treatment. However, the impact of hospital volume on survival outcomes in this population remains understudied. This study examined the relationship between hospital volume and survival among older adults (aged 65 years or older) diagnosed with TNBC.

Materials and methods

The National Cancer Database was queried for women ages ≥65 years with stage I–III TNBC diagnosed between 2010 and 2020. Annual hospital volume was the facility-level average of breast cancer cases treated in the years before the year of diagnosis. Volumes were divided into quartiles, with the lowest quartile (≤136 cases/year) defined as low-volume and the remaining three quartiles combined as high-volume. Sociodemographic, clinical, and treatment characteristics were compared according to hospital volume status. Crude and adjusted mortality risk differences and relative risks were estimated using pooled logistic regression models.

Results

The study cohort comprised 37,538 older women with TNBC, of whom 25 % (n = 9388) were treated at low-volume hospitals. Patients treated at low-volume hospitals were slightly older (73 years [IQR: 68 to 79] vs. 72 years [IQR: 68 to 78 years]) and traveled a shorter distance to the hospitals (6.80 miles [IQR: 3.00 to 14.30] vs 8.60 miles [IQR: 4.30 to 18.00]) than those treated at high-volume hospitals (p < 0.001). On adjusted analysis, treatment at low-volume hospitals (Low-Value Risk: 0.607, 95 % CI: 0.579 to 0.638) was associated with a 5.5 % increased risk of all-cause mortality compared to treatment at high-volume hospitals (High-Volume Risk: 0.576, 95 % CI: 0.556 to 0.592) (RR: 1.055, 95 % CI: 1.003 to 1.121). Patients treated at low-volume hospitals had a 3.2 % excess adjusted risk of mortality compared to those treated at higher-volume hospitals (RD: 3.2 %, 95 % CI: 0.2 % to 6.9 %).

Discussion

Older adults treated at low-volume hospitals had modestly higher mortality than those at high-volume facilities. Future work should identify mechanisms underlying this relationship and assess whether referral patterns for older adults should consider hospital volume.
老年人(≥65岁)患有三阴性乳腺癌(TNBC)的死亡率高于年轻患者,部分原因是合并症较多,治疗率较低。然而,医院容量对这一人群生存结果的影响仍未得到充分研究。本研究探讨了诊断为三阴癌的老年人(65岁或以上)住院容量与生存率之间的关系。材料和方法在国家癌症数据库中查询了2010年至2020年间诊断为I-III期TNBC的年龄≥65岁的女性。每年的医院数量是诊断前几年治疗的乳腺癌病例的医院平均水平。量被分为四分位数,最低四分位数(≤136例/年)定义为低量,其余三个四分位数合并为高量。根据医院容量状况比较社会人口学、临床和治疗特征。使用混合逻辑回归模型估计粗死亡率和调整死亡率风险差异和相对风险。结果该研究队列包括37,538名TNBC老年妇女,其中25% (n = 9388)在小容量医院接受治疗。在小规模医院接受治疗的患者年龄略大(73岁[IQR: 68至79岁]vs. 72岁[IQR: 68至78岁]),并且到医院的路程较短(6.80英里[IQR: 3.00至14.30]vs 8.60英里[IQR: 4.30至18.00]),比在大规模医院接受治疗的患者(p < 0.001)。在调整分析中,与在大医院治疗相比,在小医院治疗(低值风险:0.607,95% CI: 0.579至0.638)与全因死亡率增加5.5%相关(高值风险:0.576,95% CI: 0.556至0.592)(RR: 1.055, 95% CI: 1.003至1.121)。与在大医院治疗的患者相比,在小医院治疗的患者调整后死亡率风险高出3.2% (RD: 3.2%, 95% CI: 0.2%至6.9%)。在小容量医院治疗的老年人的死亡率略高于在大容量医院治疗的老年人。未来的工作应该确定这种关系的潜在机制,并评估老年人的转诊模式是否应该考虑医院数量。
{"title":"Impact of hospital volume on mortality in adult women over 65 with triple-negative breast cancer","authors":"Barnabas T. Obeng-Gyasi ,&nbsp;Demond L. Handley ,&nbsp;Mohamed I. Elsaid ,&nbsp;Eric Schupp ,&nbsp;Daniel G. Stover ,&nbsp;J.C. Chen ,&nbsp;Jesus D. Anampa ,&nbsp;Xiaoyi Teng ,&nbsp;Samilia Obeng-Gyasi","doi":"10.1016/j.jgo.2025.102845","DOIUrl":"10.1016/j.jgo.2025.102845","url":null,"abstract":"<div><h3>Introduction</h3><div>Older adults (≥65 years) with triple-negative breast cancer (TNBC) have higher mortality rates than younger patients, due in part to greater comorbidity and lower rates of treatment. However, the impact of hospital volume on survival outcomes in this population remains understudied. This study examined the relationship between hospital volume and survival among older adults (aged 65 years or older) diagnosed with TNBC.</div></div><div><h3>Materials and methods</h3><div>The National Cancer Database was queried for women ages ≥65 years with stage I–III TNBC diagnosed between 2010 and 2020. Annual hospital volume was the facility-level average of breast cancer cases treated in the years before the year of diagnosis. Volumes were divided into quartiles, with the lowest quartile (≤136 cases/year) defined as low-volume and the remaining three quartiles combined as high-volume. Sociodemographic, clinical, and treatment characteristics were compared according to hospital volume status. Crude and adjusted mortality risk differences and relative risks were estimated using pooled logistic regression models.</div></div><div><h3>Results</h3><div>The study cohort comprised 37,538 older women with TNBC, of whom 25 % (<em>n</em> = 9388) were treated at low-volume hospitals. Patients treated at low-volume hospitals were slightly older (73 years [IQR: 68 to 79] vs. 72 years [IQR: 68 to 78 years]) and traveled a shorter distance to the hospitals (6.80 miles [IQR: 3.00 to 14.30] vs 8.60 miles [IQR: 4.30 to 18.00]) than those treated at high-volume hospitals (<em>p</em> &lt; 0.001). On adjusted analysis, treatment at low-volume hospitals (Low-Value Risk: 0.607, 95 % CI: 0.579 to 0.638) was associated with a 5.5 % increased risk of all-cause mortality compared to treatment at high-volume hospitals (High-Volume Risk: 0.576, 95 % CI: 0.556 to 0.592) (RR: 1.055, 95 % CI: 1.003 to 1.121). Patients treated at low-volume hospitals had a 3.2 % excess adjusted risk of mortality compared to those treated at higher-volume hospitals (RD: 3.2 %, 95 % CI: 0.2 % to 6.9 %).</div></div><div><h3>Discussion</h3><div>Older adults treated at low-volume hospitals had modestly higher mortality than those at high-volume facilities. Future work should identify mechanisms underlying this relationship and assess whether referral patterns for older adults should consider hospital volume.</div></div>","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102845"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality cancer care for older adults from culturally and linguistically diverse backgrounds: Perspectives from the Cancer and Aging Research Group Junior Board 来自不同文化和语言背景的老年人的高质量癌症护理:来自癌症和老龄化研究小组初级委员会的观点。
IF 2.7 3区 医学 Q3 GERIATRICS & GERONTOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-19 DOI: 10.1016/j.jgo.2026.102853
Surbhi Singhal , Maya Abdallah , Tanyanika Phillips , Nicole A. Arrato , Mukul Roy , Samantha Werts-Pelter , Katherine Ramos , Chad Yixian Han
{"title":"Quality cancer care for older adults from culturally and linguistically diverse backgrounds: Perspectives from the Cancer and Aging Research Group Junior Board","authors":"Surbhi Singhal ,&nbsp;Maya Abdallah ,&nbsp;Tanyanika Phillips ,&nbsp;Nicole A. Arrato ,&nbsp;Mukul Roy ,&nbsp;Samantha Werts-Pelter ,&nbsp;Katherine Ramos ,&nbsp;Chad Yixian Han","doi":"10.1016/j.jgo.2026.102853","DOIUrl":"10.1016/j.jgo.2026.102853","url":null,"abstract":"","PeriodicalId":15943,"journal":{"name":"Journal of geriatric oncology","volume":"17 2","pages":"Article 102853"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146010374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of geriatric oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1